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Abstract. 
 
Matrix GLA protein (MGP), a 
 
g
 
-carboxy-
glutamic acid (GLA)–rich, vitamin K–dependent and 
apatite-binding protein, is a regulator of hypertrophic 
cartilage mineralization during development. However, 
MGP is produced by both hypertrophic and immature 
chondrocytes, suggesting that MGP’s role in mineral-
ization is cell stage–dependent, and that MGP may 
have other roles in immature cells. It is also unclear 
whether MGP regulates the quantity of mineral or min-
eral nature and quality as well. To address these issues, 
we determined the effects of manipulations of MGP 
synthesis and expression in (a) immature and hyper-
trophic chondrocyte cultures and (b) the chick limb bud 
in vivo. The two chondrocyte cultures displayed compa-
rable levels of MGP gene expression. Yet, treatment 
with warfarin, a 
 
g
 
-carboxylase inhibitor and vitamin K 
antagonist, triggered mineralization in hypertrophic but 
not immature cultures. Warfarin effects on mineraliza-
tion were highly selective, were accompanied by no ap-
preciable changes in MGP expression, alkaline phos-
phatase activity, or cell number, and were counteracted 
by vitamin K cotreatment. Scanning electron micros-
copy, x-ray microanalysis, and Fourier-transform infra-
red spectroscopy revealed that mineral forming in con-
trol and warfarin-treated hypertrophic cell cultures was 
similar and represented stoichiometric apatite. Virally 
driven MGP overexpression in cultured chondrocytes 
greatly decreased mineralization. Surprisingly, MGP 
overexpression in the developing limb not only inhib-
ited cartilage mineralization, but also delayed chondro-
cyte maturation and blocked endochondral ossiﬁcation 
and formation of a diaphyseal intramembranous bone 
collar. The results show that MGP is a powerful but de-
velopmentally regulated inhibitor of cartilage mineral-
ization, controls mineral quantity but not type, and
appears to have a previously unsuspected role in regu-
lating chondrocyte maturation and ossiﬁcation pro-
cesses.
Key words: chondrocytes • matrix GLA protein • 
mineralization • ossiﬁcation • limb development
 
M
 
INERALIZATION
 
 of the extracellular matrix is a
cell-mediated process that is required for nor-
mal development and function of skeletal and
dental tissues. For example, during endochondral bone
formation hypertrophic chondrocytes direct the deposi-
tion of hydroxyapatite crystals in the extracellular matrix
(Boyde and Shapiro, 1980; Boskey et al., 1992). Once min-
eralized, the cartilage matrix is invaded by bone and bone
marrow progenitor cell populations; this is followed by ini-
tiation of osteoblast differentiation, deposition of apatitic
mineral, and replacement of mineralized hypertrophic car-
tilage with bone (Fell, 1925; Hall, 1971; Haines, 1975).
Maintenance of normal bone structure and function is sub-
sequently dependent upon a critical balance between min-
eral deposition and resorption. Indeed, an imbalance in ei-
ther of these processes can lead to pathological conditions.
In osteoporosis, resorption exceeds deposition, leading to
bone mass and mineral losses (Manolagas and Jilka, 1995);
in atherosclerosis, the vessel-associated plaques often con-
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tain apatite crystals and may display a histological appear-
ance similar to that of lamellar bone, contributing to tissue
stiffness and loss of normal resiliency (Bostrom et al.,
1995).
Given the importance of the mineralization process in
health and disease, it is not surprising that there is intense
scrutiny of the cellular and molecular mechanisms regulat-
ing apatite deposition. Two extracellular matrix proteins,
matrix GLA protein (MGP)
 
1
 
 and osteocalcin, have at-
tracted much research interest (Price, 1985; Hale et al.,
1988; Hauschka et al., 1989; Luo et al., 1995; Neugebauer
et al., 1995; Ducy et al., 1996; Boskey et al., 1998; Munroe
et al., 1999). These proteins belong to a large family that
includes blood coagulation factors (Furie and Furie, 1988).
All members of the family contain glutamyl groups, some
of which are posttranslationally modiﬁed by a vitamin
K–dependent 
 
g
 
-carboxylase into 
 
g
 
-carboxyglutamic acid
(GLA) residues (Price, 1985; Suttie, 1985). In both MGP
and osteocalcin, the GLA residues promote binding of cal-
cium and phosphate ions. A combination of charge and
lattice geometry facilitates adsorption of calcium atoms
into the hydroxyapatite crystals (Poser and Price, 1979;
Hauschka et al., 1989). During development, MGP and os-
teocalcin preferentially accumulate in mineralized carti-
lage and bone (Mark et al., 1988; Price, 1989; Strauss et al.,
1990; Barone et al., 1991; Dohi et al., 1992; Neugebauer et
al., 1995). These findings have led to the long held view
that MGP and osteocalcin must serve important regula-
tory roles in the mineralization of skeletal and dental tis-
sues (Bronckers et al., 1985; Price, 1985; Hauschka et al.,
1989).
Pharmacological and genetic approaches have been
used to gain insights into these regulatory roles. For exam-
ple, treatment of pregnant rats with the vitamin K antago-
nist, warfarin (Suttie, 1985), reduces GLA residue synthe-
sis in the fetus and newborn and causes severe skeletal
malformations. These defects include disorganization and
excessive mineralization of growth plate and nasal septum
cartilages, precocious closure of the growth plate, growth
retardation, and abnormalities in, or absence of, ossifica-
tion centers (Price et al., 1982; Price, 1989; Feteih et al.,
1990). A similar prenatal exposure to warfarin is associ-
ated with embryopathy and skeletal defects in humans
(Hall et al., 1980). Recent genetic studies have shown that
mice lacking a functional MGP gene are viable, but exhibit
increased calcification of growth plate cartilage, short stat-
ure, osteopenia, and fractures (Luo et al., 1997). The
MGP-deficient mice die around two months of age as a re-
sult of excessive abnormal calcification of their arteries
leading to blood vessel rupture. In a related study, abla-
tion of the osteocalcin gene was also found to be compati-
ble with life (Ducy et al., 1996). Though viable, fertile, and
seemingly normal during early postnatal life, the osteocal-
cin-null mice exhibit excessive bone formation. Mutations
in the human MGP gene cause Keutel syndrome, a dis-
order characterized by excessive cartilage calcification
(Munroe et al., 1999). The above pharmacological and ge-
netic studies have led to the intriguing conclusion that, de-
spite their abundance in skeletal tissues and their ability to
bind calcium and apatite, MGP and osteocalcin may actu-
ally serve as inhibitors of cartilage mineralization and
bone formation, respectively.
There are additional intriguing and unanswered ques-
tions regarding MGP function. First, the protein is not
only present in the mineralizing zone of the growth carti-
lage, but is also present in articular cartilage and certain
nonskeletal tissues. Yet, interference with MGP function
in vivo by warfarin treatment or ablation of the MGP gene
does not lead to widespread random mineralization. Ex-
cessive mineralization is seen only at specific sites, such as
the growth cartilage and arteries (Price et al., 1982; Luo
et al., 1997). This finding raises the possibility that MGP
function in mineralization may depend on the stage of de-
velopment of the responding cells or the nature of the re-
sponding cells. A second question is whether MGP mainly
determines the quantity of mineral deposited or whether it
influences the type and quality of mineral. Last, it is not
known whether overexpression of MGP simply causes ef-
fects opposite to those seen after warfarin treatment or
MGP gene ablation, or whether there are additional ef-
fects indicative of other functions of the protein. In the
present study, we have examined these three questions.
We show that MGP is a developmentally regulated modu-
lator of chondrocyte matrix mineralization and mainly
controls mineral quantity but not quality. We show also
that constitutive MGP expression in the chick limb in vivo
not only inhibits cartilage mineralization, but also blocks
chondrocyte maturation and intramembranous and endo-
chondral ossification.
 
Materials and Methods
 
Cell Cultures
 
Immature and hypertrophic chondrocytes were isolated from the caudal
one-third portion and the cephalic core portion of day 17–18 chick embryo
sterna, respectively (Pacifici et al., 1991b; Iwamoto et al., 1993a,b). Tissue
fragments were pretreated for 2 h at 37
 
8
 
C with 0.25% trypsin to eliminate
perichondrial and blood cells, and were then treated with a fresh 0.25%
trypsin/0.1% collagenase enzyme mixture for an additional 2–3 h. The re-
sulting cell populations were filtered, recovered by centrifugation, and
plated at a density of 1.3 
 
3
 
 10
 
6
 
 cells/60-mm tissue culture dish or 2 
 
3
 
 10
 
5
 
cells/22-mm well (12 well plates). Cells were grown continuously, without
subculturing, for 
 
z
 
2 wk in monolayer. During the first 2 d, cultures re-
ceived 4 U/ml of testicular hyaluronidase to minimize cell detachment
(Leboy et al., 1989). Cultures were fed every other day with Dulbecco’s
modified high glucose Eagle’s medium containing 10% fetal calf serum,
2 mM 
 
L
 
-glutamine, and 50 U/ml penicillin and streptomycin (complete
medium) (Pacifici et al., 1991a).
To allow cells to deposit mineral, conﬂuent cultures received complete
medium supplemented with 5 mM 
 
b
 
-glycerophosphate to serve as a phos-
phate source and with 25 
 
m
 
g/ml ascorbic acid or 35 nM all-trans-retinoic
acid to serve as mineralization cofactors (Leboy et al., 1989; Iwamoto et
al., 1993a). Complete medium supplemented with ascorbate and 
 
b
 
-glyc-
erophosphate was termed medium A, and complete medium supple-
mented with retinoic acid and 
 
b
 
-glycerophosphate was termed medium B.
Mineral was revealed by staining with alizarin red (McGee-Russel, 1958).
When indicated, cultures were treated with 3–10 
 
m
 
M vitamin K, warfarin,
or a combination of both biochemicals. Stock solutions (1,000
 
3
 
) of war-
farin and vitamin K3 were made in saline, whereas vitamin K1 and K2
stock solutions were made in 95% ethanol. Untreated cultures received
equal volumes of vehicle. During treatment, the medium was changed daily.
 
1. 
 
Abbreviations used in this paper: 
 
APase, alkaline phosphatase; FT-IR,
Fourier transform infrared spectroscopy; GLA, 
 
g
 
-carboxyglutamic acid;
MGP, matrix GLA protein; pNP, p-nitrophenyl phosphate; RT-PCR, re-
verse transcriptase PCR; SEM, scanning electron microscopy. 
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Determination of Alkaline Phosphatase (APase) and 
Calcium Content
 
The APase activity of the cell layer was measured using p-nitrophenyl
phosphate (pNP) as a substrate (Pacifici et al., 1991b). Cells were scraped
from the dish, recovered by centrifugation, and resuspended in ice-cold
0.9% NaCl in 3 mM Tris-HCl, pH 7.4. One half of each cell suspension
was centrifuged for 1 min in a microfuge (10,000 
 
g
 
) and the resulting cell
pellet was solubilized in 0.9% NaCl and 0.2% Triton X-100. Samples were
clarified by centrifugation for 5 min and the supernatants were mixed with
one volume of 1 M Tris-HCl, pH 9.0, containing 1 mM pNP and 1 mM
MgCl
 
2
 
. The reaction was stopped by addition of 0.25 vol of 1 N NaOH,
and hydrolysis of pNP was monitored as a change in absorbance at 410 nm.
The remaining half of each cell suspension was used to determine DNA
content (Johnson-Wint and Hollis, 1982).
For calcium determination, cultures in multiwell plates were rinsed
three times with 0.9% NaCl in 10 mM Tris-HCl, pH 7.4, and extracted
with 0.5 ml/well of 1 N HCl for 30 min at room temperature. The calcium
concentration in the extract was determined by atomic absorption spec-
trophotometry (Perkin-Elmer 2380) in the presence of 0.1% LaCl
 
3
 
 (Iwa-
moto et al., 1993a).
 
Northern Blot Analysis
 
Total RNAs were isolated from chondrocyte cultures as described (Paciﬁci
et al., 1991b; Iwamoto et al., 1993b). For Northern blot analysis, 10
 
 m
 
g of
total RNA denatured by glyoxalation was fractionated on 1% agarose gels
and transferred to Hybond-N membrane. Blots were stained with 0.04%
methylene blue to verify that each sample had been transferred efficiently.
Blots were hybridized in 6
 
3
 
 SSC, 5
 
3
 
 Denhardt’s solution, 100 
 
m
 
g/ml
sheared salmon sperm DNA, 2% SDS, and 50% formamide at 45
 
8
 
C over-
night with 
 
32
 
P-labeled cDNA MGP probe. A 306-bp full-length chick
MGP cDNA clone was prepared in the pTA vector by reverse tran-
scriptase PCR (RT-PCR), using primers designed on published sequence
(Wiedemann et al., 1998). The EcoRI-BamHI insert was excised and la-
beled with [
 
32
 
P]CTP by random priming. Blots were exposed to Kodak
x-ray Bio-Max films at 
 
2
 
70
 
8
 
C for different lengths of time to insure linear-
ity of exposure.
 
Fourier Transform Infrared (FT-IR) Analysis
 
This procedure was carried out as described (Iwamoto et al., 1993b; Rey
et al., 1995; Gadaleta et al., 1996). Cultures were rinsed three times with
0.9% NaCl in 10 mM Tris-HCl, pH 7.4, freeze-dried at 
 
2
 
60
 
8
 
C, and stored
dessicated. Samples were analyzed by FT-IR spectroscopy using a Nicolet
Magna–IR spectrometer operated in the diffuse reflectance mode. Each
sample was gently milled in an agate mortar and layered on KBr at a KBr:
sample ratio of 300:1 (wt/wt). Routinely, 300 interferograms were col-
lected at 4 cm
 
2
 
1
 
 resolution; the background was subtracted using a non-
mineralized chondrocyte preparation. Spectra were co-added and the
resulting interferograms were fourier transformed; second derivative
spectra (1,200–500 cm
 
2
 
1
 
) were obtained using a software package (Om-
nic). Resolution factors are presented in the legend of each figure.
 
Scanning Electron Microscopy (SEM) and
X-ray Microanalysis
 
Chondrocyte monolayer cultures were processed for these analyses as de-
scribed previously (Harrison et al., 1995). In brief, cultures were rinsed
with PBS, fixed with 1:1 dilution of Karnovsky’s fixative for 30 min, post-
fixed with full strength Karnovsky for 1 h, and then dehydrated by incuba-
tion in 10, 30, 50, 70, 80, 90, 95, and 100% ethanol (15 min each); incuba-
tion with 100% ethanol was repeated twice. After removal of the last
ethanol, the cells were covered with Freon 113; the dishes were sealed
with parafilm in which a few holes were punctured with a needle, and
were allowed to dry slowly under a hood overnight. A circle 
 
z
 
2 cm in di-
ameter was cut from each dish and mounted by colloidal silver paint onto
an aluminum stub and cells were carbon sputter–coated. Samples were
viewed using a JEOL T330A scanning electron microscope and were si-
multaneously examined by energy dispersive x-ray microanalysis using
Kevex hardware (Kevex Corp.) with Quantex 5 software.
 
RCAS Construction and Room Temperature–PCR 
(RT-PCR) Analysis
 
The entire coding sequence of chick MGP (Wiedemann et al., 1998) was
amplified by RT-PCR (see below) and subcloned into the RCAS(A) ret-
roviral vector (Hughes et al., 1987). The resulting plasmid (RCAS-MGP)
was resequenced to verify sequence fidelity. Recombinant plasmid DNA
was transfected into chick embryo fibroblasts by a FuGENE6 transfection
reagent (Boehringer Mannheim). Recombinant viral particles released
into the medium were concentrated using a centrifugation concentrator
and used to infect freshly isolated chondrocytes (Iwamoto et al., 1993b).
For determination of efficiency of viral infection, cultured chondro-
cytes were detached by trypsinization and replated onto poly-
 
L
 
-lysine–
coated dishes at a density of 2 
 
3
 
 10
 
6
 
 cells/ml. After 15 min, adhered cells
were washed with PBS twice, fixed with 3.7% neutralized formaldehyde
solution for 5 min, and permeabilized by incubation with PBS containing
0.5% Triton X-100 for 15 min. Cells were incubated with hybridoma cul-
ture supernatant containing AMV-3C2, a mouse mAb against the gag pro-
tein of avian myeloblastosis virus and recognizing cells harboring avian
Rous sarcoma or leukemia virus. Detection of bound antibody was ob-
tained by the ABC method using Histofine kits (Nichirei).
RT-PCR was carried out as described (Enomoto-Iwamoto et al., 1998).
1
 
 m
 
g of whole cellular RNA was reverse transcribed by Superscript re-
verse transcriptase (GIBCO BRL) and random hexamers. After reverse
transcription, samples were amplified for the indicated number of cycles
using Elongase (GIBCO BRL) at the following conditions: 10 s at 95
 
8
 
C
for denaturation and 1 min at 60
 
8
 
C for annealing and extension. The se-
quences of chick MGP primers were based on the report by Wiedemann
et al. (1998) and were: 5
 
9
 
 GAGTGAGGCACAGCAAGAGACA 3
 
9
 
 and
5
 
9
 
 AGGAGGTTACCCTGAGGTCCAA 3
 
9
 
, generating a 402-bp frag-
ment. The chick cytoplasmic 
 
b
 
-actin primers were as follows: 5
 
9
 
 AAG-
GAGAAGCTGTGCTACGTCG 3
 
9
 
 and 5
 
9
 
 CTTCTGCATCCTGTCAG-
CAATG 3
 
9
 
, generating a 309-bp fragment (Kost et al., 1983).
 
Implantations in Chick Embryo Limb Buds and In
Situ Hybridization
 
Chick embryo ﬁbroblasts transfected with RCAS-MGP or control insert-
less RCAS plasmids were grown to conﬂuency in monolayer. Small cell
layer fragments, 
 
z
 
200–300 
 
m
 
m
 
2
 
, were scraped off the culture dish surface
and were microsurgically implanted in the mesenchyme at the distal re-
gion of the leg bud of Hamburger-Hamilton stage 22–23 chick embryos
(Koyama et al., 1996). Eggs were returned to the incubator and allowed to
develop further. At the indicated time points, embryos were removed
from eggs, sacrificed, and examined visually or under a dissecting scope to
determine the gross effects of experimental manipulations on limb devel-
opment. Control and experimental limbs were removed, fixed in 4%
paraformaldehyde, embedded in paraffin, and sectioned. Sections were
processed for general histology by staining with hematoxylin and eosin
stains and for histochemical detection of mineral by staining with 0.5%
alizarin red S solution, pH 4.0, for 5 min at room temperature.
Companion continuous 5-
 
m
 
m sections were processed for in situ hy-
bridization using 
 
35
 
S-labeled riboprobes as described previously (Koyama
et al., 1996) to determine the gene expression patterns of MGP, type II
collagen, and type X collagen. The cDNA clones used were the following:
a full-length chick MGP clone prepared by RT-PCR (see above), the 0.8-
kb chick type II collagen clone pDLr2, and the 0.197-kb chick type X col-
lagen clone pDLr10 (Leboy et al., 1989).
 
Results
 
Warfarin Effects on Mineralization in
Cultured Chondrocytes
 
In the ﬁrst set of experiments, we determined whether in-
terference with endogenous MGP function by treatment
with the vitamin K antagonist, warfarin, causes excessive
matrix mineralization regardless of the stage of matura-
tion of chondrocytes or whether the effects are develop-
mentally regulated. To this end, conﬂuent multiwell cul-
tures of immature and hypertrophic chick embryo sternal
chondrocytes were treated with 10 
 
m
 
M warfarin for 4 d in
medium containing supplements required for mineral dep-
osition in culture, namely the phosphate donor 
 
b
 
-glycero-
phosphate and the collagen synthesis cofactor ascorbic 
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acid (hereafter called medium A). As controls, companion
cultures were treated with warfarin plus vitamin K1 or vi-
tamin K1 alone, or were left untreated. To detect mineral-
ization, cultures were stained with alizarin red or subjected
to cell layer–associated calcium content analysis. We found
that warfarin treatment had no appreciable effects on min-
eralization in immature chondrocyte cultures (Fig. 1, A
and B); these cultures all contained 
 
z
 
1–1.5 
 
m
 
g/
 
m
 
g DNA of
cell layer–associated calcium. However, the warfarin treat-
ment markedly stimulated mineralization of the hyper-
trophic cultures (Fig. 1, I and J); cell-associated calcium
content increased from 
 
z
 
3.3 
 
6
 
 0.4 
 
m
 
g/
 
m
 
g DNA in control
to 11.2 
 
6
 
 2.1 
 
m
 
g/
 
m
 
g DNA in warfarin-treated cultures. The
warfarin stimulation of mineralization was counteracted
by cotreatment with vitamin K1 (Fig. 1 L), attesting to the
specificity of warfarin effects. Vitamin K1 alone had no
obvious effects in either hypertrophic (Fig. 1 K) or imma-
ture cultures (Fig. 1, C and D). Vitamin K2 and K3 gave
identical results (not shown); thus, the three vitamins were
used interchangeably hereafter.
To insure that the differential responses above were spe-
ciﬁc, reﬂected the cells’ potentials to mineralize, and were
not inﬂuenced by the type of mineralization cofactors
used, similar conﬂuent immature and hypertrophic cul-
tures were grown for 4 d in medium supplemented with
 
b
 
-glycerophosphate and retinoic acid (hereafter called
medium B). In earlier studies, we showed that retinoic acid
is a stronger stimulator of mineralization-related activities in
chondrocytes (Iwamoto et al., 1993a). Cultures in medium
B were treated with 10 mM warfarin, 10 mM vitamin K, or
both as above. Even in this medium, warfarin treatment
failed to stimulate matrix mineralization in immature cul-
tures (Fig. 1, E–H), but did so in hypertrophic cultures
 
(Fig. 1, M and N). Calcium content increased from 14.4 
 
6
 
2.7 
 
m
 
g/
 
m
 
g DNA in control hypertrophic cultures to 32.6 
 
6
 
4.2 
 
m
 
g/
 
m
 
g DNA after warfarin treatment. This stimulation
was counteracted by cotreatment with vitamin K (Fig. 1
P). Interestingly, the substantial mineralization seen in
control hypertrophic cultures (Fig. 1 M) was partially
counteracted by treatment with vitamin K (Fig. 1 O),
which decreased the cell layer-associated calcium content
to 9.1 6 1.8 
 
m
 
g/
 
m
 
g DNA.
To investigate whether higher doses of warfarin or
longer treatment periods could actually induce mineraliza-
tion in immature cultures, cultures in medium A and B
were treated with 10, 20, or 30 
 
m
 
M warfarin for 4 d; paral-
lel cultures were treated for 8 d. We found that neither the
higher warfarin concentrations used (Fig. 2, A–H) nor the
longer treatment period (not shown) resulted in mineral-
ization of immature chondrocyte cultures.
Figure 1. Micrographs of multiwell cultures of
immature (A–H) and hypertrophic (I–P) stained
with alizarin red to reveal mineralization. Con-
ﬂuent cultures in medium A or medium B were
treated with 10 mM warfarin (B, F, J, and N), 10
mM vitamin K3 (C, G, K, and O), and both war-
farin and vitamin K (D, H, L, and P) for 4 d.
Companion control cultures received vehicle
alone (A, E, I, and M).
Figure 2. Micrographs of conﬂuent immature cultures grown in
medium A or B, treated for 4 d with 10, 20, or 30 mM warfarin,
and stained with alizarin red. 
Yagami et al. 
 
Matrix GLA Protein and Chondrocyte Mineralization
 
1101
 
To determine the relationship between mineralization
responses and endogenous MGP gene expression, cultures
of immature and hypertrophic chondrocytes in medium A
or medium B were treated as above and were processed
for Northern blot analyses. We found that both immature
and hypertrophic cultures contained obvious amounts of
the 1.3- and 3.0-kb MGP RNAs (Fig. 3, A and B, respec-
tively) (Wiedemann et al., 1998). Cultures in medium A
contained two to threefold more MGP transcripts (Fig. 3,
A and B, lane 1) than cultures in medium B (Fig. 3, A and
B, lane 5). However, these basal levels of expression were
not significantly affected by treatment with warfarin, vita-
min K, or warfarin plus vitamin K (Fig. 3, A–B, lanes 1–8).
Since APase is an enzyme whose activity is closely asso-
ciated with the mineralization process, we determined the
activity of the phosphatase in control and warfarin-treated
hypertrophic cultures. We found no change in APase ac-
tivity per cell as a result of warfarin and vitamin K treat-
ments or cotreatments in either medium A or medium B
(Fig. 4, A and B). This analysis also showed that warfarin
treatment had no effect on cell number (Fig. 4, C and D).
Thus, MGP function in mineralization as revealed by war-
farin interference depends on the stage of chondrocyte
maturation, does not appear to be related to MGP expres-
sion levels, and does not involve changes in APase activity.
 
Analysis of Mineral
 
We determined next whether MGP regulates only the
quantity of mineral deposited by cells in their matrix or
may also affect mineral nature and overall quality. Thus,
we compared the mineral deposited by control and war-
farin-treated hypertrophic chondrocytes by SEM, x-ray
 
microanalysis, and FT-IR spectroscopy. Cells used for
these experiments were grown in medium B because they
formed more mineral than cells in medium A (Fig. 1).
When viewed by SEM, many crystals were observed on,
and to be associated with, the cell surface in both control
and warfarin-treated cells (Fig. 5, A and B). When exam-
ined at a higher magnification, each crystal displayed a
typical multibead organization, with beads averaging 200–
400 nm in diameter (Fig. 5 B, inset). After SEM, multiple
microscopic fields were subjected to x-ray microanalysis.
Prominent phosphorus and calcium peaks were produced
by crystals in both cultures (Fig. 5, C and D). Integration
of the peaks showed that the calcium/phosphorus molar
ratio was 
 
z
 
1.3–1.4, thus, resembling that of apatite in hy-
pertrophic cartilage (Boyde and Shapiro, 1980; Boskey
et al., 1992).
To examine the mineral composition in greater detail,
mineral samples from control and warfarin-treated cul-
tures were examined by FT-IR spectroscopy (Fig. 6). The
samples elicited similar second derivative spectra in the v
 
1
 
v
 
3
 
 phosphate region 1,200–950 cm
 
2
 
1
 
 (Fig. 6, A and B), with
clear peaks at 1,160, 1,102, 1,028, 962, and 906 cm
 
2
 
1
 
 that are
characteristic of stoichiometric hydroxyapatite. Likewise,
similar second derivative spectra were observed in the v
 
4
 
phosphate domain 650–500 cm
 
2
 
1
 
 (Fig. 6, C and D) with
strong peaks at 606 and 565 cm
 
2
 
1
 
 attributable to phos-
phate ions in apatite, and in the v
 
2
 
 carbonate region 890–
850 cm
 
2
 
1
 
 (Fig. 6, E and F). Bands at 880, 875, and 872
cm
 
2
 
1
 
 in the carbonate region indicated that CO
 
3
 
 had at
least in part substituted for OH and PO
 
4
 
, and that carbon-
ate apatite was present in the mineralized cultures. Thus,
Figure 3. Northern blot analysis of MGP gene expression. Con-
ﬂuent immature (A) and hypertrophic (B) cultures in medium A
or medium B were treated for 4 d with warfarin, vitamin K, or
both. Blots (10 mg RNA/lane) were stained with methylene blue
to reveal the ribosomal bands and to verify equal loading and
transfer efficiency. Blots were hybridized with a 32P-labeled MGP
probe and exposed to x-ray films. The two main 3.0- and 1.3-kb
MGP transcripts are indicated.
Figure 4. Histograms showing levels of APase activity and DNA
content in hypertrophic chondrocyte cultures. Conﬂuent cultures
grown in medium A (A and C) and medium B (B and D) were
left untreated (solid bars) or were treated with 10 mM warfarin
(open bars) for 4 d in the absence or presence of indicated doses
of vitamin K. After treatment, aliquots of the cell layer were used
for determination of APase activity and DNA content. 
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qualitatively similar mineral is deposited by hypertrophic
chondrocytes in the absence or presence of warfarin. In
both cases, the mineral has morphological, organizational,
and biochemical characteristics of apatite crystals display-
ing relatively low crystallinity, typical of mineralizing cells
in culture as well as young bone tissue in vivo (Roufosse
et al., 1984; Rey et al., 1991; Iwamoto et al., 1993b; Rey
et al., 1995).
 
MGP Overexpression in Cultured Chondrocytes
We asked next whether the amount of MGP expressed by
hypertrophic chondrocytes is a factor influencing the
mineralization potential of the cells. To address this ques-
tion, we constructed an RCAS-based expression vector
(Hughes et al., 1987) encoding full-length chick MGP and
used the resulting viral particles (RCAS-MGP) to infect
freshly isolated hypertrophic chondrocyte populations. As
a control, companion cells were infected with insertless
RCAS viral particles. Cultures were grown for z1 wk until
confluent, and were processed for RT-PCR to estimate the
levels of MGP gene expression and for immunocytochem-
istry to determine the percentage of virally infected cells in
control and RCAS-MGP cultures, using an antibody to the
viral structural protein p19. We found that MGP gene ex-
pression was significantly higher in RCAS-MGP cultures
(expressing both endogenous and virally encoded MGP)
(Fig. 7 B) than in control cultures (expressing endogenous
MGP only) (Fig. 7 A). Housekeeping actin gene expres-
sion was identical in both cell populations (Fig. 7, C and
D). Immunocytochemistry revealed that z60% of the cells
in both control and RCAS-MGP cultures were virally in-
fected (Fig. 7, E and F, respectively).
To determine the effects of MGP overexpression on
mineralization, companion multiwell cultures were main-
tained in mineralization medium A or B for 7 d (rather
than 4 d as in the experiments above) to induce optimal
mineralization. At the end of this period, cultures (in du-
plicate) were stained with alizarin red to reveal mineral
deposition. Control cultures were clearly stained by aliz-
arin red (Fig. 8 A, RCAS), indicating that the cells had
Figure 5. Scanning electron
micrographs of chondrocyte
cultures (A and B) and x-ray
element microanalysis of
mineral present (C and D).
Conﬂuent hypertrophic cul-
tures in medium B were
treated with 10 mM warfarin
for 4 d (B and D) or were left
untreated (A and C), and
were then processed for SEM
and x-ray analyses. Note the
numerous mineral crystal de-
posits present in both cul-
tures (A and B). Inset in B is
a higher magnification view
of one such deposit revealing
its multibead structure. X-ray
analysis of crystals (C and D)
shows that they contain
prominent phosphorus (P)
and calcium (Ca) peaks in ra-
tios typical of biologic apa-
tite. The position of sulfur (S)
and iron (Fe) is indicated.
Figure 6. FT-IR analysis of mineral. Conﬂuent hypertrophic
chondrocyte cultures were left untreated (A, C, and E) or were
treated for 4 d with 10 mM warfarin for 4 d (B, D, and F) in me-
dium B. After treatment, cell layers were processed for mineral
harvest and samples were analyzed by FT-IR.Yagami et al. Matrix GLA Protein and Chondrocyte Mineralization 1103
mineralized their matrix and that infection by insertless vi-
rus had no deleterious effect on mineralization. In com-
parison, cultures infected with the RCAS-MGP virus ex-
hibited signiﬁcantly reduced alizarin red staining (Fig. 8 B,
RCAS-MGP). When control cultures were treated with 10
mM vitamin K1 or K2 for the last 7 d of culture, mineral-
ization was also reduced (Fig. 8, C and E, RCAS); indeed,
when RCAS-MGP cultures were similarly treated with vi-
tamin K, mineralization was completely prevented (Fig. 8,
D and F, RCAS-MGP).
MGP Overexpression In Vivo
We asked next whether MGP overexpression in the devel-
oping chick limb would have similar inhibitory effects on
the mineralization process of long bones. A small pellet of
fibroblasts producing RCAS-MGP or control RCAS vi-
ruses was implanted in the vicinity of the mesenchymal
condensations of tibia and fibula present in stage 22–23
(day 3.5–4.0) chick embryo hindlimb buds. We aimed to
infect only these skeletal elements and to use uninfected
femur and tarsal elements as an internal control. Embryos
were reincubated until day 10–12, and longitudinal sec-
tions through the entire legs were prepared and processed
for histology, histochemistry, and in situ hybridization.
Analysis of alizarin red–stained sections from control day
12 embryo showed that the femur (fe), tibia (ti), and tarsal
(ta) elements displayed their typical elongated morphol-
ogy, and that their alizarin red staining diaphyses were un-
dergoing mineralization and ossification (Fig. 9 A). In con-
trast, in RCAS-MGP–infected embryos, the tibia failed to
stain with alizarin red (Fig. 9 B); unexpectedly, the tibia
was also significantly shorter and broader than the control.
These changes were limited to the tibia since femur and
tarsal elements in the RCAS-MGP leg were normal and
stained with alizarin red (Fig. 9 B). Higher magnification
analysis of alizarin red–stained or hematoxylin/eosin–
stained sections showed that the diaphysis of control tibia
contained hypertrophic mineralizing cartilage (Fig. 9 E,
arrowhead) and endochondral bone (not shown), was sur-
rounded by a mineralized intramembranous bone collar
(Fig. 9, C and E, arrow), and was being invaded by marrow
cells (Fig. 9 E, double arrow). In contrast, the diaphysis of
RCAS-MGP tibia was entirely cartilaginous (Fig. 9, D and
F). There was no evidence of erosion or invasion by mar-
row cells, and there was a lack of a bone collar (Fig. 9 D,
arrow). In addition, the diaphyseal chondrocytes were not
fully hypertrophic (Fig. 9 F, arrowheads) and displayed
average cell diameters smaller than those in the control
(Fig. 9 E).
To confirm and extend these observations, we carried
out in situ hybridization on similar longitudinal sections of
day 12 control (Fig. 10, A–C) and RCAS-MGP (Fig. 10,
D–F) tibia, using probes encoding cartilage characteristic
type II and X collagens and MGP. It should be noted that,
because of their different lengths, about one half of the
control tibia is shown in Fig. 10, A–C, whereas the entire
RCAS-MGP tibia is shown in Fig. 10, D–F. In control tibia
(Fig. 10 A), transcripts encoding type II collagen were
abundant in the epiphyseal articular layer and underlying
growth plate containing proliferating, prehypertrophic,
and hypertrophic chondrocytes; the transcripts were re-
duced in late posthypertrophic chondrocytes (Fig. 10 A),
as reported previously (Leboy et al., 1988; Iyama et al.,
1991). Transcripts encoding type X collagen, a product
typical of hypertrophic chondrocytes, were abundant in
hypertrophic and posthypertrophic chondrocytes (Fig. 10
B). MGP transcripts displayed more complex patterns
reminiscent of those seen in mouse embryos (Luo et al.,
1997; Komori et al., 1997); they were prominent in the ar-
ticular layer (Fig. 10 C, arrow), in proliferating/prehyper-
trophic chondrocytes along the lateral side of tibia (Fig. 10
C, double arrowhead), and in posthypertrophic chondro-
cytes (Fig. 10 C, double arrow). Notably, MGP transcripts
were essentially undetectable in the entire hypertrophic
zone, either along its lateral side (Fig. 10 C, arrowhead) or
its central region.
However, in the RCAS-MGP tibia, the type II collagen
transcripts were equally abundant from epiphysis to dia-
physis (Fig. 10 D) and the type X collagen transcripts were
quite scarce (Fig. 10 E). This indicated that the respective
downregulation and upregulation of these two genes, nor-
mally associated with chondrocyte hypertrophy, had not
occurred and that chondrocyte maturation had indeed
been inhibited. As expected, MGP transcripts were very
prominent and present throughout tibia and neighboring
tissues, reflecting the presence of both endogenous and vi-
rally derived transcripts (Fig. 10 F).
Discussion
The results of the study provide clear evidence that MGP
roles in endochondral ossification are under tight cellular
control. In hypertrophic chondrocyte cultures, interfer-
ence with GLA residue synthesis by warfarin treatment
Figure 7. RT-PCR and immunocytological analyses of chondro-
cyte cultures. Freshly isolated cephalic sternal chondrocytes in-
fected with control viral particles (RCAS) or viral particles en-
coding MGP (RCAS-MGP) were grown for z1 wk in medium A.
Cultures were processed for RT-PCR analysis of MGP (A and B)
and b-actin (C and D) expression or for immunocytochemical de-
termination of virally infected cells (E and F), using an antibody
to the viral protein p19. Note that infected cells are dark/black,
whereas uninfected cells are light gray.The Journal of Cell Biology, Volume 147, 1999 1104
causes rapid and extensive mineralization; in immature
chondrocyte cultures, a similar treatment does not cause
mineralization. This differential response is not simply be-
cause of differences in MGP levels, since there is little dif-
ference in the levels of MGP gene expression in the two
cell populations. We find also that mineral deposited by
hypertrophic cells in the absence or presence of warfarin
treatment is qualitatively similar and represents biological
apatite. We infer from this observation that MGP mainly
controls the degree of mineralization, rather than the qual-
ity or type of mineral deposited. Last, we find that virally
driven overexpression of MGP in cultured hypertrophic
chondrocytes causes a marked decrease in mineralization.
This finding lends further strength to the inhibitor studies,
and indicates that in mineralization-competent cells, the
amount of MGP plays a critical role in the mineralization
process. As might be expected, MGP overexpression in
the limb bud in vivo causes a marked reduction in mineral-
ization. However, we did not anticipate to also observe
that such overexpression delays chondrocyte maturation,
causes shortening and broadening of the skeletal elements,
and blocks both endochondral and intramembranous ossi-
fications. This data provides new evidence that MGP roles
in skeletogenesis may extend beyond the regulation of
mineralization.
GLA-containing Proteins and Mineralization
In our inhibitor studies, we examined the effects of war-
farin on the mineralization of hypertrophic chondrocytes
under two conditions, medium A and medium B. In earlier
investigations, we showed that both conditions induce ex-
pression of many cellular activities associated with the ter-
minal mineralization phase of maturation, including in-
creased APase activity, decreased type X collagen gene
expression, and shifts in energy metabolism (Leboy et al.,
Figure 8. Histochemical determination of mineral in control
(RCAS) and MGP-overexpressing (RCAS-MGP) cultures. Cul-
tures similar to those described in Fig. 7 legend were grown for
z2 wk until confluent. Cultures (in duplicate) were grown for an
additional 7 d in medium A in the absence (none) or presence of
10 mM vitamin K1 or K2. At the end of the treatment, cultures
were stained with alizarin red to reveal mineralization.
Figure 9. Histological analyses of the effects of
MGP overexpression on limb long bone develop-
ment. In the control limb, femur (fe), tibia (ti),
and tarsal (ta) elements display normal elon-
gated morphology (A). Their diaphyses stain
positively with alizarin red (A), are surrounded
by an intramembranous bone collar (C and E, ar-
row), and display fully hypertrophic chondro-
cytes (E, arrowhead) and invading marrow cells
(E, double arrow). In RCAS-MGP limb, tibia is
completely cartilaginous and does not stain with
alizarin red (B); its diaphysis lacks both a bone
collar (D, arrow) and fully hypertrophic chondro-
cytes (F, arrowheads). Bars (A and B) 2.5 mm;
(C–F) 80 mm.Yagami et al. Matrix GLA Protein and Chondrocyte Mineralization 1105
1989; Iwamoto et al., 1993b; Shapiro et al., 1994). We now
show that in either condition, warfarin treatment does not
elicit major changes in MGP expression, APase activity, or
cell number. Thus, because the treatment enhances miner-
alization in both conditions, it is clear that the charged car-
boxyl groups by themselves serve as critical sites for the
regulation of mineral deposition by MGP. A previous
study showed that osteocalcin is expressed by hyper-
trophic sternal chondrocytes in culture (Neugebauer et al.,
1995), suggesting that this protein and its carboxyl groups
may also have contributed to the regulation of mineraliza-
tion. Ongoing analyses of the absolute amounts, distribu-
tion, and timing of expression of osteocalcin and MGP
should clarify the respective contributions of these pro-
teins to mineralization in the hypertrophic chondrocyte
cultures used here.
Effort was extended in evaluating the quality of the min-
eral formed in hypertrophic cell cultures. FT-IR analysis,
SEM, x-ray microanalysis, and measurements of calcium/
phosphate ratios all show that the mineral deposited in the
presence of warfarin treatment is indistinguishable from
that deposited in untreated cultures and represents normal
carbonate apatite. The only difference observed is that
much more mineral is deposited in warfarin-treated cul-
tures, lending support to our conclusion that a critical role
of MGP is to control the initiation of mineralization and
the amount of mineral deposited. This conclusion corre-
lates well with previous pharmacological, biochemical, and
genetic studies (Price, 1985; Romberg et al., 1986; Luo et
al., 1997), indicating that MGP and other calcium-binding
proteins act as strong inhibitors of the initiation phase of
mineralization. Given the self-sustaining and self-promot-
ing nature of the mineralization process, the presence of
these strong inhibitors may be needed to restrict mineral-
ization to the appropriate sites and times in the embryo
and growing organism. Once the first seed crystals form,
however, MGP and other calcium-binding proteins may
have additional roles, including controlling size, rates of
growth, directionality, and maturation of mineralization.
A recent study has provided evidence that osteocalcin may
have a role in mineral maturation in the growing animal
(Boskey et al., 1998). These considerations and our find-
ings reiterate the idea that mineralization is complex and
that multiple mechanisms are needed to regulate it during
embryogenesis and postnatal life.
How could MGP exert its control on the initiation phase
of mineralization? Given its ability to bind calcium, the
protein could simply serve as a competitor and limit the
amount of calcium ions available to initiate calcification
(Romberg et al., 1986). Mineralization is thought to ini-
Figure 10. In situ hybridization analysis of gene expression patterns in control (A–C) and MGP-overexpressing (D–F) tibia. Only about
half of the control tibia is shown in A-C, whereas the entire RCAS-MGP tibia is shown in D–F. Note in C the particularly strong MGP
expression in articular layer (arrow), along the lateral side of the proliferative and prehypertrophic zones (double arrowheads), and in
posthypertrophic zone (double arrow); barely detectable signal is seen throughout the hypertrophic zone (arrowhead). II, type II col-
lagen; X, type X collagen. Art., articular layer; Prol., proliferative zone; Prehyp., prehypertrophic zone; and Posthyp., posthypertrophic
zone. Bar, 250 mm.The Journal of Cell Biology, Volume 147, 1999 1106
tiate in matrix vesicles (Landis, 1986; Genge et al., 1989;
Anderson, 1990; Kirsch and Wuthier, 1994) and/or at focal
sites of proteoglycan accumulation (Hunter, 1987; Poole,
1991). MGP has actually been found to be associated with
matrix vesicles isolated from articular and growth plate
cartilage (Loeser et al., 1992). In this location, MGP would
be in an ideal topographical position to inhibit or compete
with calcium influx into the vesicle’s lumen and inhibit the
vesicle’s capability to initiate mineralization. Likewise,
MGP could limit the amount of calcium ions available for
binding to focally accumulated proteoglycans. It is impor-
tant to note that there are additional mechanisms limiting
mineralization. For example, we have shown previously
that there actually are two structurally and functionally
distinct types of matrix vesicles produced by chondrocytes
(Kirsch et al., 1997). Others have shown that the focal ac-
cumulations of proteoglycans are restricted to hyper-
trophic cartilage and are not common in cartilages not in-
volved in mineralization (Poole, 1991). Thus, MGP is part
of multiple mechanisms that serve to control mineraliza-
tion and allow it to occur only at appropriate sites, times,
and levels in the organism.
This conclusion correlates well with the phenotype of
MGP-null mice (Luo et al., 1997). Lack of MGP was found
to lead to excessive or ectopic mineralization of specific
tissues and structures such as the growth plate, aorta, and
tracheal rings. However, articular cartilage, a tissue rich in
MGP (Hale et al., 1988), was not reported to be abnor-
mally mineralized. Clearly, this tissue must possess multi-
ple means by which mineralization is prevented, even in
the absence of MGP. Multiple inhibitory means must also
characterize the immature chondrocytes used in our study,
which do not mineralize their matrix once treated with
warfarin. On the other hand, susceptible tissues such as
blood vessels must possess a strong potential to mineral-
ize, and will do so simply in the absence of MGP. This
would account for the relatively high frequency with which
arteries undergo pathological calcification in conditions
such as atherosclerosis (Bostrom et al., 1995).
MGP Gene Expression, Chondrocyte Maturation,
and Ossification
Our in vivo data show that virally driven misexpression of
MGP causes severe alterations of limb skeletogenesis. We
find that the MGP-overexpressing tibia is shorter and
wider than its normal counterpart, and the maturation
process of growth plate chondrocytes is severely inhibited.
In addition, the diaphysis fails to be invaded by bone and
marrow progenitor cells, to undergo endochondral ossifi-
cation, and to be surrounded by an intramembranous bone
collar. Interestingly, it was found in MGP-null mice that
the growth plates of limb skeletal elements are not only
more mineralized than those present in control animals,
but are also disorganized and lack characteristic chondro-
cyte columns (Luo et al., 1997). It is clear that absence or
overexpression of MGP are both incompatible with the
normal processes of chondrocyte maturation, cartilage
mineralization, and ossifications.
It was shown previously in mouse embryo limb skeletal
elements that the normal gene expression pattern of MGP
is very complex (Komori et al., 1997; Luo et al., 1997);
MGP expression is low in the proliferative zone of growth
plate, strong in the prehypertrophic zone, low again in the
hypertrophic zone, and strong again in the posthyper-
trophic mineralizing zone (Komori et al., 1997; Luo et al.,
1997). We show here that the MGP gene expression pat-
tern in chick growth plates is equally complex. The signifi-
cance and biological consequences of these highly distinc-
tive patterns of expression have remained largely unclear.
In view of the results shown here and those in the MGP-
null mouse study, it is conceivable that the MGP expres-
sion patterns may not only be related to mineralization,
but may also have roles in chondrocyte and cartilage de-
velopment. In particular, the downregulation of MGP
gene expression in zones of the growth plate, and in the
hypertrophic zone in particular, may actually be required
for chondrocyte maturation and the emergence of hyper-
trophic chondrocytes. By maintaining constant MGP ex-
pression and preventing modulations of expression, the vi-
rally driven MGP misexpression may have blocked the
cells at more immature stages and inhibited their further
development into hypertrophic cells. The absence of fully
hypertrophic chondrocytes would explain the lack of both
endochondral ossification and invasion by bone and mar-
row progenitor cells, since only hypertrophic mineralizing
cartilage can serve as a substrate for these processes. The
absence of fully hypertrophic chondrocytes would also ac-
count for the reduction in skeletal element length since hy-
pertrophy is the main determinant of longitudinal growth
(Hunziker, 1994). The lack of a diaphyseal intramembra-
nous bone collar is harder to explain. It may be a direct
consequence of widespread virally driven MGP expression
acting on perichondrial tissues and inhibiting their differ-
entiation into osteoblasts. Alternatively, it may be an indi-
rect consequence of the failure of cartilage to become fully
hypertrophic; it was suggested long ago that cartilage and
perichondrial tissues are characterized by mutual interde-
pendence and interactions, and that alterations in one tis-
sue may have developmental repercussions in the other
tissue (Fell, 1925; Thorogood, 1983). Whatever the expla-
nation, the absence of an intramembranous bone collar
would account for the increased width of the MGP-over-
expressing skeletal element, given that the collar has a pri-
mary role in regulating the diameter of the shaft in devel-
oping long bones.
We do not know yet how MGP exerts influences on
chondrocyte and cartilage maturation beyond its roles in
mineralization. MGP may act via mechanisms indepen-
dent of its ability to bind calcium and apatite, i.e., mecha-
nisms unrelated to those involved in mineralization. Alter-
natively, MGP may again use its calcium binding ability to
influence chondrocyte maturation. A previous study pro-
vides indirect support for the latter possibility. It was
found that increases in extracellular calcium concentra-
tions selectively induce expression of type X collagen in
chondrocyte cultures (Bonen and Schmid, 1991). Because
type X collagen is a marker of maturing and hypertrophic
chondrocytes, the finding indicates that extracellular cal-
cium can favor the hypertrophic program. A similar in-
crease in available calcium could occur in zones of the
growth plate with low MGP expression, such as the hyper-
trophic zone; in other words, low MGP gene expression
may signify increased free calcium available for cellularYagami et al. Matrix GLA Protein and Chondrocyte Mineralization 1107
activities and for promotion and completion of the chon-
drocyte maturation program.
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